Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018.

ABSTRACT:

Introduction

Information about survival outcomes in metastatic biliary tract cancer (BTC) is sparse, and the numbers often quoted are based on reports of clinical trials data that may not be representative of patients treated in the real world. Furthermore, the impact of more widespread adoption of a standardized combination chemotherapy regimen since 2010 on survival is unclear.

Methods

We performed an analysis of the Surveillance, Epidemiology, and End Results database to determine the real-world overall survival trends in a cohort of patients with metastatic BTC diagnosed between the years 2000 and 2017 with follow-up until 2018. We analyzed data for the entire cohort, evaluated short-term and long-term survival rates, and compared survival outcomes in the pre-2010 and po

SUBMITTER: Nghiem V 

PROVIDER: S-EPMC10668577 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature